3med
From Proteopedia
(Difference between revisions)
m (Protected "3med" [edit=sysop:move=sysop]) |
|||
| Line 1: | Line 1: | ||
[[Image:3med.png|left|200px]] | [[Image:3med.png|left|200px]] | ||
| - | <!-- | ||
| - | The line below this paragraph, containing "STRUCTURE_3med", creates the "Structure Box" on the page. | ||
| - | You may change the PDB parameter (which sets the PDB file loaded into the applet) | ||
| - | or the SCENE parameter (which sets the initial scene displayed when the page is loaded), | ||
| - | or leave the SCENE parameter empty for the default display. | ||
| - | --> | ||
{{STRUCTURE_3med| PDB=3med | SCENE= }} | {{STRUCTURE_3med| PDB=3med | SCENE= }} | ||
===HIV-1 K103N Reverse Transcriptase in Complex with TMC125=== | ===HIV-1 K103N Reverse Transcriptase in Complex with TMC125=== | ||
| - | |||
| - | <!-- | ||
| - | The line below this paragraph, {{ABSTRACT_PUBMED_20438081}}, adds the Publication Abstract to the page | ||
| - | (as it appears on PubMed at http://www.pubmed.gov), where 20438081 is the PubMed ID number. | ||
| - | --> | ||
{{ABSTRACT_PUBMED_20438081}} | {{ABSTRACT_PUBMED_20438081}} | ||
| Line 22: | Line 11: | ||
==See Also== | ==See Also== | ||
| - | *[[Reverse transcriptase]] | + | *[[Reverse transcriptase|Reverse transcriptase]] |
==Reference== | ==Reference== | ||
| - | <ref group="xtra">PMID: | + | <ref group="xtra">PMID:020438081</ref><references group="xtra"/> |
[[Category: Hiv-1 m:b_hxb2r]] | [[Category: Hiv-1 m:b_hxb2r]] | ||
[[Category: RNA-directed DNA polymerase]] | [[Category: RNA-directed DNA polymerase]] | ||
Revision as of 04:41, 18 July 2012
Contents |
HIV-1 K103N Reverse Transcriptase in Complex with TMC125
Template:ABSTRACT PUBMED 20438081
About this Structure
3med is a 2 chain structure of Reverse transcriptase with sequence from Hiv-1 m:b_hxb2r. Full crystallographic information is available from OCA.
See Also
Reference
- Lansdon EB, Brendza KM, Hung M, Wang R, Mukund S, Jin D, Birkus G, Kutty N, Liu X. Crystal Structures of HIV-1 Reverse Transcriptase with Etravirine (TMC125) and Rilpivirine (TMC278): Implications for Drug Design. J Med Chem. 2010 May 3. PMID:20438081 doi:10.1021/jm1002233
